2Mingione M J, Pressman EK, Woods R.Prevention of PPROM: current and future strategies [J]. J Maternal Fetal Neonatal Med, 2006, 19: 783-9.
3Maymon E, Romero R, Pacora P, et al. Evidece for the participation of interstitial collgenase (matrix metalloproteinase 1 in preterm rupture ofmembrances [ J ]. Am J Obstet Gynecol, 2000, 183:914-20.
4Maymon E, Romero R, Pacora P, et al. Human neutrophil collgenase (matrix metalloproteinase 8 in preterm rupture ofmembrances, and intrauterine infection[J]. Am J Obstet Gynecol, 2000, 183: 94-9.
5Fujimoto T, Parry S, Urbanek M, et al. A single nucleotide polymorphism in the matrix metalloproteinase -1 (MMP-1) promoter influences arnnion cell MMP-I expression and risk for preterm premature rupture of the fetal membranes[J]. Biol Chem, 2002, 277: 6296-302.
6Ferrand PE, Samuel PS, Samme M, et al. A polymorphism in preterm premature rupture of membrances in African Americans [J ]. Mol Human Reprod, 2002, 8: 494-501.
7Pemi SC, Vardhana S, Kalish R, et al. Clara cell protein 16 concentraton in mid trimester amniotic fluid: association with fetal gender, fetal G>A+38CC16 gene polymorphism and pregnancy outcome [J]. Reprod lmmunol, 2005, 68: 85-90.
8Collins FS, Brooks LD, Ahakravarti A, et al. DNA polymorphism discovery resource for research on human genetic variation [J]. Genome Res, 1998, 8: 12291.
9Sephen J, Fortunato R P, Menon K F, et al. Inflammatory cytokine ( interleukine-1 ,6, and 8 and tumor necrosis factor-a) release from cultured human fetal membranes in response to endotoxic lipopoly- saccharide mirrors amniotic fluid concentrations [ J ]. Am J Obstet Gynecol, 1996,174 ( 6 ) : 1855.
10Weiss A, Goldman S, Shalev E. The matrix metalloproteinases (MMPS) in the decidua and fetal membranes [ J]. Front Biosci, 2007,12(1) : 649 -59.
